Medication use and overuse in people with migraine

At EAN 2022, Gisela Terwindt, Professor of Neurology, Leiden University Medical Centre, Leiden, The Netherlands, introduced herself and discussed how many patients with migraine symptoms are actually unaware they have migraine. As a result, they take only acute, over-the-counter medications and do not discuss symptoms with a healthcare professional. People who are diagnosed with migraine may also take acute medication, including triptans, but may not take it within the right time window, and/or they may take medication over a number of days, leading to medication overuse headache. This is especially a problem for women and people who menstruate as migraine at this time can be more severe, be of longer duration, and be unresponsive to triptans for at least some of this time. Professor Terwindt discussed how some healthcare professionals and patients are not well educated regarding these problems and patients may not be properly instructed on correct medication usage, including that of preventative medication, for migraines.

 

EAN: EAN: European Association of Neurology

Disclaimer: The video represent the opinion of the speaker. Lundbeck does not recommend the use of drugs outside of its registered indications. Please always consult the Summary of Product Characteristics.

BE-NOTPR-0300, approval date 05/2023 

You are leaving Progress in Mind
Hello
Please confirm your email
We have just sent you an email, with a confirmation link.
Before you can gain full access - you need to confirm your email.
The information on this site is exclusively intended for health care professionals.
All the information included in the Website is related to diseases, investigations and existing or potential treatment options and, therefore, directed to health professionals . The technical information of the drugs is provided merely informative, being the responsibility of the professionals authorized to prescribe drugs and decide, in each concrete case, the most appropriate treatment to the needs of the patient.
Congress
Register for access to Progress in Mind in your country